Product Details
| Product Name:
Trontinemab |
CAS No.:
2568868-35-7 |
| Purity:
99.00% |
Supply Ability:
10g |
| Release date:
2025/12/12 |
Product Introduction
Bioactivity
| Name | Trontinemab |
| Description | Trontinemab (RG6102) is a human IgG1-κ antibody selectively targeting Aβ precursor protein (APP) with transferrin receptor p90, CD71 (TFRC), inhibits amyloid production, and can be used to study neurological disorders such as Alzheimer's disease. |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Keywords | βAmyloid | β Amyloid | BetaAmyloid | Beta Amyloid | bAmyloid | b Amyloid | Aβ |
| Inhibitors Related | BSBM7 | Notoginsenoside R1 | Geniposide | Deferoxamine Mesylate | Tramiprosate | 20(S)-Ginsenoside Rg3 | PQM130 | HEPPS | Dihydroergocristine mesylate | Rutin | Methyl tridecanoate | DAPT |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
-
CAS:2068138-14-5
$58.00 / 10mg
-
CAS:957511-97-6
$44.00 / 25mg
-
CAS:1262108-14-4
$195.00 / 1mg
Recommended supplier
| Product name |
Price |
|
Suppliers |
Update time |
|
|
$/ |
|
Anhui Ruihan Technology Co., Ltd
|
2023-08-21 |
United States